Currently, the mainly proposed therapeutic intervention for AD is anti-amyloid approach, which ranges from interdicting amyloidogenic processing of the β-amyloid precursor protein (APP) to removing amyloid plaques in the brain [13]. This evidence concerns the gene APP and Alzheimer disease.